Avance is a company specialized in valuation in life sciences located in Basel, Switzerland. We serve a wide range of clients around the globe including biotechs, big pharma, medtechs, hedge funds, investors, banks, and technology transfer offices.
We stand for tailored and outstanding work
- Tailored solutions
- Satisfied clients
- Companies' education
We, at Avance, believe in tailored and fact-based solutions for each of our clients. We understand that every company is unique in the existing capabilities and approaches to solve current market gaps. It is our goal to capture the maximum value of projects and technologies, provide the management with a clear elaboration on the results, and help to steer the companies towards most value adding strategic decisions.
We are determined to professionalize valuation in the life sciences industry. In that perspective, we engage with the community in life sciences through social portals, publish many of our insights in our wide-spread newsletter, and distribute educational materials on valuation-related topics. A detailed summary and description of our approach are published in the industry reference book “Valuation in Life Sciences. A Practical Guide”.
Valuation in Life Sciences
This book is the first complete guide to valuation in life sciences for industry professionals, investors, and academics. It has rapidly become the standard reference in the industry and is currently published in its third edition.
Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation and provide valuable industry data. After guiding the reader through the theory of valuation, including discounted cash-flow and real options, the authors demonstrate how to value projects, patents, licenses, firms and stocks on real-life examples, even treating complex license and company structures.
Special emphasis is put on the practicability of the proposed methods by including many hands-on examples, without compromising on realistic results.